Tyra Biosciences, Inc. (TYRA) Cash Flow Statement
Tyra Biosciences, Inc. (TYRA) generated -$109.7M of operating cash flow over the twelve months to 2026-06-30, spent $250000 on capital expenditure and had free cash flow of -$109.9M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TYRATyra Biosciences, Inc.Follow TYRA — free
—
Price chart with a free account
- Market cap
- 1.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -23.7 | -50.3 | -50.1 | -69.8 | -95.1 | -109.7 | |
| Capital expenditure | 0.7 | 0.6 | 0.8 | 0.7 | 0.1 | -0.3 | |
| Free cash flow | -24.4 | -50.8 | -50.9 | -70.4 | -95.3 | -109.9 | |
| Stock-based compensation | 2.9 | 10.6 | 13.5 | 22.8 | 28.0 | — |
USD millions · SEC XBRL
Tyra Biosciences, Inc. — questions
- What is Tyra Biosciences, Inc.'s operating cash flow?
- -$109.7M over the twelve months to 2026-06-30.
- How much does Tyra Biosciences, Inc. spend on capital expenditure?
- $250000 over the twelve months to 2026-06-30.
- What is Tyra Biosciences, Inc.'s free cash flow?
- -$109.9M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Tyra Biosciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.